Purchase Order 15DDPH25P00000004

Award Date 11/15/24
Potential Completion Date 9/30/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
William Penn Annex East, PA 19106, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of 15DDHQ25P00000008, was issued by the Drug Enforcement Administration (DEA), a civilian agency under the U.S. Department of Justice. The $15,000.00 contract was awarded to Gene S. Kennedy, M.D., P.C., a veteran-owned small business, to provide medical expert services including Prescription Drug Monitoring Program (PDMP) analysis, patient file reviews, case consultation, and expert witness testimony for federal drug-related investigations and...
This is a federal contract award from the Drug Enforcement Administration (DEA) to Gene S. Kennedy, M.D., P.C., a for-profit, veteran-owned small business, for expert witness consulting services. The contract, valued at $15,000.00, is a firm-fixed-price purchase order with a period of performance from March 3, 2025, to September 30, 2025. The contract does not have a set-aside designation. The contract appears to be for medical expert witness services, including Prescription Drug Monitoring...
The U.S. Drug Enforcement Administration (DEA) awarded a $24,500 firm-fixed-price purchase order to Gene S. Kennedy, M.D., P.C., a veteran-owned small business, to provide medical expert witness services and analysis for controlled substance diversion investigations and prosecutions during fiscal year 2024. The contract, which does not have a set-aside designation, will run through December 5, 2024. Dr. Kennedy, an experienced pain management specialist, will perform tasks such as Prescription...
This is a $10,000.00 purchase order contract awarded by the Drug Enforcement Administration (DEA) to Gene S. Kennedy, M.D., P.C., a veteran-owned small business, for expert medical consulting services. The contract is for a 1-year period of performance from May 22, 2025 to May 21, 2026 and does not have a set-aside designation. The contract involves the provision of specialized professional services such as Prescription Drug Monitoring Program (PDMP) analysis, patient file reviews, case...
This federal contract award, valued at $23,500.00, was issued by the Drug Enforcement Administration (DEA) to Gene S. Kennedy, M.D., P.C., a veteran-owned small business located in St. Simons Island, Georgia. The contract is for the provision of expert medical consulting services, including Prescription Drug Monitoring Program (PDMP) analysis, patient file reviews, case consultations, and expert witness testimony related to controlled substance diversion investigations and prosecutions. The...
This federal contract award to Gene S. Kennedy, M.D., P.C., a veteran-owned small business, provides specialized medical expertise and professional services to the Drug Enforcement Administration (DEA) and U.S. Attorney's Offices. The $10,000.00 purchase order contract, which does not have a set-aside designation, is for Dr. Kennedy to provide analysis of Prescription Drug Monitoring Program (PDMP) data, patient chart review, case consultation, and expert witness testimony for controlled...
This is a $21,500.00 purchase order contract awarded by the Drug Enforcement Administration (DEA), a civilian federal agency, to Gene S. Kennedy, M.D., P.C., a veteran-owned small business located in St. Simons Island, Georgia. The contract is for expert medical opinion and analysis services related to the DEA's Prescription Drug Monitoring Program (PDMP) investigations and controlled substance diversion cases. The contract has a period of performance through January 11, 2025 and is structured...
This federal contract award is for expert witness services and professional medical analysis provided by Gene S. Kennedy, M.D., P.C. to the Drug Enforcement Administration (DEA), a civilian agency under the U.S. Department of Justice (DOJ). The $1,250 purchase order contract covers Dr. Kennedy's services, including Prescription Drug Monitoring Program (PDMP) analysis, patient file reviews, and expert witness testimony related to controlled substance diversion investigations and prosecutions. The...
The U.S. Drug Enforcement Administration (DEA) awarded a $5,000.00 firm-fixed-price purchase order contract to Gene S. Kennedy, M.D., P.C., a veteran-owned small business, for expert witness consulting services. The contract has an ultimate completion date of September 30, 2024. The company, doing business as Kennedy, Gene S Office, provides specialized medical expertise and professional services, primarily to the Department of Justice and its components, including expert witness testimony,...
This federal contract award to Gene S. Kennedy, M.D., P.C., doing business as Kennedy, Gene S Office, provides $22,500.00 in firm fixed price funding for the Drug Enforcement Administration (DEA), a component of the U.S. Department of Justice (DOJ). The contract, awarded on October 27, 2023, is for specialized medical expert witness services, analysis, and consultation to support DEA and DOJ investigations and prosecutions related to controlled substance diversion. The work, which has a...

The federal contract award with ID 15DDPH25P00000004 was issued by the Drug Enforcement Administration (DEA), a civilian agency within the U.S. Department of Justice, to Gene S. Kennedy, M.D., P.C., a veteran-owned small business. The $4,000.00 firm-fixed-price purchase order is for the services of Dr. Kennedy as a subject matter expert to provide Prescription Drug Monitoring Program (PDMP) analysis, patient file reviews, case consultation, and expert witness testimony to support the DEA's controlled substance diversion investigations and prosecutions. The period of performance is from November 15, 2024 to September 30, 2025. This contract award does not have a set-aside designation.

Generated 11/14/24, 9:12 AM